Hedström M, Haglund K, Skolin I, von Essen L (2003) Distressing events for children and adolescents with cancer: child, parent, and nurse perceptions. J Pediatr Oncol Nurs 20:120–32

Article  PubMed  Google Scholar 

Phillips RS, Gibson F, Houghton E, Gopaul S, Craig JV, Pizer B (2016) Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood (an update). Cochrane Database Syst Rev 2(2). https://doi.org/10.1002/14651858.CD007786.pub3

Chang T (2015) Nausea and vomiting. Supportive care in pediatric oncology: a practical evidence-based approach, 1st edn. Springer Berlin Heidelberg Imprint Springer, pp 159–175

Book  Google Scholar 

Paw Cho Sing E, Robinson PD, Flank J, Holdsworth M, Thackray J, Freedman J, Gibson P, Orsey AD, Patel P, Phillips R, Portwine C, Raybin JL, Cabral S, Sung L, Dupuis LL (2019) Classification of the acute emetogenicity of chemotherapy in pediatric patients: a clinical practice guideline. Pediatr Blood Cancer 66(5):e27646

Article  PubMed  Google Scholar 

Patel P, Robinson, PD, Cohen, M et al (2022) Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: a clinical practice guideline. Pediatr Blood Cancer 69. https://doi.org/10.1002/pbc.30001

Patel P, Robinson PD, Devine KA, Positano K, Cohen M, Gibson P, Holdsworth M, Phillips R, Spinelli D, Thackray J, van de Wetering M, Woods D, Cabral S, Sung L, Dupuis LL (2021) Prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: clinical practice guideline update. Pediatr Blood Cancer 68. https://doi.org/10.1002/pbc.28947

Patel P RP, Thackray J, Flank J, Holdsworth MT, Gibson P et al (2017) Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: a focused update. Pediaticr Blood Cancer 64. https://doi.org/10.1002/pbc.26542

Dupuis LLSL, Molassiotis A, Orsey AD, Tissing W, van de Wetering M (2017) MASCC/ESMO consensus recommendations: prevention of acute chemotherapy-induced nausea and vomiting in children. 2017(25):323-31

CCLG CsCaLG (2018) Guideline on the management of chemotherapy induced nausea and vomiting. Available from: https://www.piernetwork.org/uploads/4/7/8/1/47810883/cclg_cinv_guideline_march_2018.pdf.  Accessed Aug 2024

Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA et al (2020) Antiemetics: ASCO guideline update. J Clin Oncol 38(24):2782–2797

Article  PubMed  CAS  Google Scholar 

Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA et al (2017) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35(28):3240–3261

Article  PubMed  CAS  Google Scholar 

Dupuis LLBS, Sung L, Portwine C, Hain R, McCarthy P, Holdsworth M, Pediatric Oncology Group of Ontario (2011) Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer 57(2):191–8

Article  PubMed  Google Scholar 

Phillips RS, Gopaul S, Gibson F, Houghton E, Craig JV, Light K et al (2010) Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood. Cochrane Database Syst Rev 9:CD007786

Google Scholar 

Crane SBM (2017) Understanding ethical issues of research participation from the perspective of participating children and adolescents: a systematic review. Worldviews Evid Based Nurs 14(3):200–209

Article  PubMed  PubMed Central  Google Scholar 

Bloomfield F (2015) The challenges of research participation by children. Pediatr Res 78:109–110

Article  PubMed  Google Scholar 

Peake JNBE, Oostendorp LJM et al (2022) Research barriers in children and young people with life-limiting conditions: a surve. BMJ Support Palliat Care 12:e715–e721

Article  PubMed  Google Scholar 

Dias SWN, Jansen JP, Sutton A (2018) Network meta-analysis for decision making. Wiley

Book  Google Scholar 

Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784

Article  PubMed  Google Scholar 

Rohatgi A (2022) WebPlotDigitizer version 4.6. Available from: https://automeris.io/WebPlotDigitizer. Accessed Aug 2024

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366. https://doi.org/10.1136/bmj.l4898

Rhodes KM, Turner RM, Higgins JP (2016) T Empirical evidence about inconsistency among studies in a pair-wise meta-analysis. Res Syn Meth 7:346–370

Article  Google Scholar 

Forni C, Ferrari S, Loro L, Mazzei T, Beghelli C, Biolchini A, Simoni P, Tremosini M, Strazzari S, Puggioli C, Bacci G (2000) Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions. Support Care Cancer 8:131–133

Article  PubMed  CAS  Google Scholar 

Koseoglu V, Kurekci AE, Sarici U, Atay AA, Ozcan O (1998) Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. Eur J Pediatr 157:806–810

Article  PubMed  CAS  Google Scholar 

Luisi FA, Petrilli AS, Tanaka C, Caran EM (2006) Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma. Sao Paulo Med J 124:61–65

Article  PubMed  PubMed Central  Google Scholar 

Sepulveda-Vildosola AC, Betanzos-Cabrera Y, Lastiri GG, Rivera-Marquez H, Villasis-Keever MA, Del Angel VW et al (2008) Palonosetron hydrochloride is an effective and safe option to prevent chemotherapy-induced nausea and vomiting in children. Arch Med Res 39(6):601–606

Article  PubMed  CAS  Google Scholar 

Alvarez O, Freeman A, Bedros A, Call SK, Volsch J, Kalbermatter O, Halverson J, Convy L, Cook L, Mick K et al (1995) Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol 17:145–150

Article  PubMed  CAS  Google Scholar 

Berrak SG, Ozdemir N, Bakirci N, Turkkan E, Canpolat C, Beker B et al (2007) A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy. Support Care Cancer 15(10):1163–1168

Article  PubMed  Google Scholar 

Cakir FB, Yapar O, Canpolat C, Akalin F, Berrak SG (2012) Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial. Support Care Cancer 20(10):2451–2457

Article  PubMed  CAS  Google Scholar 

Jaing TH, Tsay PK, Hung IJ, Yang CP, Hu WY (2004) Single-dose oral granisetron versus multidose intravenous ondansetron for moderately emetogenic cyclophosphamide-based chemotherapy in pediatric outpatients with acute lymphoblastic leukemia. Pediatr Hematol Oncol 21(3):227–235

Article  PubMed  CAS  Google Scholar 

Komada Y, Matsuyama T, Takao A, Hongo T, Nishimura Y, Horibe K, Sakurai M (1999) A randomised dose-comparison trial of granisetron in preventing emesis in children with leukaemia receiving emetogenic chemotherapy. Eur J Cancer 35:1095–1101

Article  PubMed  CAS  Google Scholar 

Patil V, Prasada H, Prasad K, Shenoy UV (2015) Comparison of antiemetic efficacy and safety of palonosetron vs ondansetron in the prevention of chemotherapy-induced nausea and vomiting in children. J Community Support Oncol 13(6):209–213

Article  PubMed  Google Scholar 

Stiakaki E, Savvas S, Lydaki E, Bolonaki I, Kouvidi E, Dimitriou H et al (1999) Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Pediatr Hematol Oncol 16(2):101–108

Article  PubMed  CAS  Google Scholar 

Eghbali A, Kohpar FK, Ghaffari K, Afzal RR, Eghbali A, Ghasemi A (2023) Evaluating aprepitant single-dose plus granisetron and dexamethasone in children receiving highly emetogenic chemotherapy for the prevention of chemotherapy-induced nausea and vomiting: a triple-blinded randomized clinical trial. Hematol Transfus Cell Ther 45(3):281–289

Article  PubMed  Google Scholar 

Tsuchida Y, Hayashi Y, Asami K, Yamamoto K, Yokoyama J, Mugishima H, Honna T, Mimaya J, Hara F, Sawada T, Matsumura T, Suita S, Sugimoto T, Kaneko M (1999) Effects of granisetron in children undergoing high-dose chemotherapy: a multi-institutional, cross-over study. Int J Oncol 14:673–679

PubMed  CAS  Google Scholar 

Brock P, Brichard B, Rechnitzer C, Langeveld NE, Lanning M, Soderhall S, Laurent C (1996) An increased loading dose of ondansetron: a North European, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2. Eur J Cancer 32:1744–1748

Article  Google Scholar 

Sandoval C, Corbi D, Strobino B, Fevzi Ozkaynak M, Tugal O, Jayabose S (1999) Randomized double-blind comparison of single high-dose ondansetron and multiple standard-dose ondansetron in chemotherapy-naive pediatric oncology patients. Cancer Invest 17(5):309–313

Article  PubMed  CAS  Google Scholar 

Ruktrirong J, Traivaree C, Monsereenusorn C, Photia A, Lertvivatpong N, Rujkijyanont P (2021) Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy-induced nausea and vomiting among children: a comparative randomized double-blind controlled trial. Pediatr Blood Cancer 68(6):e29002

Article  PubMed  CAS  Google Scholar 

White L, Daly SA, McKenna CJ, Zhestkova N, Leal C, Breatnach F et al (2000) A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy. Pediatr Hematol Oncol 17(6):445–455

Article